150 related articles for article (PubMed ID: 1868505)
1. Early hepatitis during intravenous amiodarone administration.
Morelli S; Guido V; De Marzio P; Aguglia F; Balsano F
Cardiology; 1991; 78(3):291-4. PubMed ID: 1868505
[TBL] [Abstract][Full Text] [Related]
2. Probable early acute hepatitis with parenteral amiodarone.
Lupon-Rosés J; Simó-Canonge R; Lu-Cortez L; Permanyer-Miralda G; Allende-Monclús H
Clin Cardiol; 1986 May; 9(5):223-5. PubMed ID: 3708949
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis induced by parenteral amiodarone.
Gregory SA; Webster JB; Chapman GD
Am J Med; 2002 Aug; 113(3):254-5. PubMed ID: 12208392
[No Abstract] [Full Text] [Related]
4. [Acute hepatitis caused by intravenous amiodarone].
Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
[TBL] [Abstract][Full Text] [Related]
5. Acute hepatitis after parenteral amiodarone administration.
Pye M; Northcote RJ; Cobbe SM
Br Heart J; 1988 Jun; 59(6):690-1. PubMed ID: 3395527
[TBL] [Abstract][Full Text] [Related]
6. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine treats intravenous amiodarone induced liver injury.
Mudalel ML; Dave KP; Hummel JP; Solga SF
World J Gastroenterol; 2015 Mar; 21(9):2816-9. PubMed ID: 25759554
[TBL] [Abstract][Full Text] [Related]
8. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
[TBL] [Abstract][Full Text] [Related]
9. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatitis complicating intravenous amiodarone treatment.
Agozzino F; Picca M; Pelosi G
Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
[TBL] [Abstract][Full Text] [Related]
11. [Acute hepatitis following amiodarone administration].
Tagliamonte E; Cice G; Ducceschi V; Mayer MS; Iacono A
Minerva Cardioangiol; 1997 Sep; 45(9):451-6. PubMed ID: 9446068
[TBL] [Abstract][Full Text] [Related]
12. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?
Rhodes A; Eastwood JB; Smith SA
Gut; 1993 Apr; 34(4):565-6. PubMed ID: 8491409
[TBL] [Abstract][Full Text] [Related]
13. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy.
James PR; Hardman SM
Heart; 1997 Jun; 77(6):583-4. PubMed ID: 9227310
[No Abstract] [Full Text] [Related]
14. Acute liver injury after intravenous amiodarone: a case report.
Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
[TBL] [Abstract][Full Text] [Related]
15. Acute amiodarone liver toxicity likely due to ischemic hepatitis.
Gluck N; Fried M; Porat R
Isr Med Assoc J; 2011 Dec; 13(12):748-52. PubMed ID: 22332445
[TBL] [Abstract][Full Text] [Related]
16. Acute toxic hepatitis after amiodarone intravenous loading.
Rizzioli E; Incasa E; Gamberini S; Savelli S; Zangirolami A; Tampieri M; Manfredini R
Am J Emerg Med; 2007 Nov; 25(9):1082.e1-4. PubMed ID: 18022508
[No Abstract] [Full Text] [Related]
17. Use, value, and toxicity of amiodarone.
Rothenberg F; Franklin JO; DeMaio SJ
Heart Dis Stroke; 1994; 3(1):19-23. PubMed ID: 8137059
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
Schmidt A; König W; Binner L; Mayer U; Stauch M
Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512
[TBL] [Abstract][Full Text] [Related]
19. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
Chen CC; Wu CC
Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity associated with amiodarone therapy.
Flaharty KK; Chase SL; Yaghsezian HM; Rubin R
Pharmacotherapy; 1989; 9(1):39-44. PubMed ID: 2646621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
